-
Product Insights
NewNet Present Value Model: Clearside BioMedical Inc’s Axitinib
Empower your strategies with our Net Present Value Model: Clearside BioMedical Inc's Axitinib report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Company Insights
Innovation and Patenting activity of Lifecore Biomedical Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Lifecore Biomedical Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Jafron Biomedical Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Jafron Biomedical Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of Shin Nippon Biomedical Laboratories Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Shin Nippon Biomedical Laboratories Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Company Insights
Innovation and Patenting activity of Shenzhen New Industries Biomedical Engineering Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Shenzhen New Industries Biomedical Engineering Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request....
-
Product Insights
NewArtificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview The artificial pancreas aids people in controlling their blood glucose level or diabetes, primarily type 1, automatically by continuously providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise artificial pancreas clinical trials outlook. The regulatory paths followed for conducting the artificial pancreas pipeline...
-
Product Insights
Spirometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spirometers Pipeline Market Report Overview A spirometer is designed to measure the amount of air inhaled or exhaled by a patient and the rate at which the air is moved into or out of the lungs in a lung function test. The spirometers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Product Insights
NewCardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GEA-001 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GEA-001 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GEA-001 in Rheumatoid Arthritis Drug Details: GEA-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levoxiracetam in Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levoxiracetam in Cognitive Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levoxiracetam in Cognitive Impairment Drug Details: L-oxiracetam is under development for the...